Journal article · 2022 · Open access

Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery

Hanwen Zhang, Xuexiang Han, Mohamad‐Gabriel Alameh, Sarah J. Shepherd, Marshall Scott Padilla, Lulu Xue, Kamila Butowska, Drew Weissman, Michael J. Mitchell

Journal of Biomedical Materials Research Part A, 110(5), 1101–1108 · Published 25 January 2022 · DOI 10.1002/jbm.a.37356

Open PDFView at the publisherCite this paper

In brief

“Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery” is a 2022 journal article by Hanwen Zhang and 8 co-authors, published in Journal of Biomedical Materials Research Part A. OpenAlex counts 88 citations as of 18 November 2026, which puts it in the top 3% of works published in 2022 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
88
Most cited in
2026 (28)
Field-weighted impact
4.14
References
41
Authors
9

Abstract

Lipid nanoparticles (LNPs) play a crucial role in delivering messenger RNA (mRNA) therapeutics for clinical applications, including COVID-19 mRNA vaccines. While mRNA can be chemically modified to become immune-silent and increase protein expression, LNPs can still trigger innate immune responses and cause inflammation-related adverse effects. Inflammation can in turn suppress mRNA translation and reduce the therapeutic effect. Dexamethasone (Dex) is a widely used anti-inflammatory corticosteroid medication that is structurally similar to cholesterol, a key component of LNPs. Here, we developed LNP formulations with anti-inflammatory properties by partially substituting cholesterol with Dex as a means to reduce inflammation. We demonstrated that Dex-incorporated LNPs effectively abrogated the induction of tumor necrosis factor alpha (TNF-ɑ) in vitro and significantly reduced its expression in vivo. Reduction of inflammation using this strategy improved in vivo mRNA expression in mice by 1.5-fold. Thus, we envision that our Dex-incorporated LNPs could potentially be used to broadly to reduce the inflammatory responses of LNPs and enhance protein expression of a range of mRNA therapeutics.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhang, H., Han, X., Alameh, M., Shepherd, S. J., Padilla, M. S., Xue, L., Butowska, K., Weissman, D., & Mitchell, M. J. (2022). Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery. Journal of Biomedical Materials Research Part A, 110(5), 1101–1108. https://doi.org/10.1002/jbm.a.37356

MLA 9

Zhang, Hanwen, et al. “Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery.” Journal of Biomedical Materials Research Part A, vol. 110, no. 5, 2022, pp. 1101–1108. https://doi.org/10.1002/jbm.a.37356.

Chicago

Zhang, Hanwen, Xuexiang Han, Mohamad‐Gabriel Alameh, Sarah J. Shepherd, Marshall Scott Padilla, Lulu Xue, Kamila Butowska, Drew Weissman, and Michael J. Mitchell. 2022. “Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery.” Journal of Biomedical Materials Research Part A 110 (5): 1101–1108. https://doi.org/10.1002/jbm.a.37356.

Harvard

Zhang, H. et al. (2022) ‘Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery’, Journal of Biomedical Materials Research Part A, 110(5), pp. 1101–1108. doi:10.1002/jbm.a.37356.

IEEE

H. Zhang et al., “Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery,” Journal of Biomedical Materials Research Part A, vol. 110, no. 5, pp. 1101–1108, 2022, doi: 10.1002/jbm.a.37356.

BibTeX

@article{zhang2022rational,
  title     = {{Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery}},
  author    = {Zhang, Hanwen and Han, Xuexiang and Alameh, Mohamad‐Gabriel and Shepherd, Sarah J. and Padilla, Marshall Scott and Xue, Lulu and Butowska, Kamila and Weissman, Drew and Mitchell, Michael J.},
  journal   = {Journal of Biomedical Materials Research Part A},
  year      = {2022},
  volume    = {110},
  number    = {5},
  pages     = {1101--1108},
  doi       = {10.1002/jbm.a.37356},
  url       = {https://doi.org/10.1002/jbm.a.37356}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202255
20231313
20242020
20252222
20262828

Its field-weighted citation impact is 4.14: it has been cited 4.14 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • mRNA delivery
  • dexamethasone
  • anti-inflammatory lipids
  • innate immune response
  • TNF-α
  • mRNA vaccines
  • COVID-19 vaccines

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zhang, H., Han, X., Alameh, M., Shepherd, S. J., Padilla, M. S., Xue, L., Butowska, K., Weissman, D., & Mitchell, M. J. (2022). Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery. Journal of Biomedical Materials Research Part A, 110(5), 1101–1108. https://doi.org/10.1002/jbm.a.37356

How many times has this paper been cited?

88 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the PDF from this page.

Who wrote this paper?

Hanwen Zhang, Xuexiang Han, Mohamad‐Gabriel Alameh, Sarah J. Shepherd, Marshall Scott Padilla, Lulu Xue, Kamila Butowska, Drew Weissman, Michael J. Mitchell.

What is the DOI of this paper?

10.1002/jbm.a.37356, permanently at https://doi.org/10.1002/jbm.a.37356. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.